trial · primary record
Lunsekimig
Chronic Rhinosinusitis With Nasal Polyps
| Phase | Phase 2 |
|---|---|
| Status | ACTIVE |
| Sponsor | Unknown |
| Enrolment | 71 |
| Primary completion | 2029-02-22 |
| Primary endpoint | Incidence of participants with treatment-emergent adverse events (TEAEs) including adverse events of special interest (AESI), and serious adverse events (SAEs) |
| Registry ID | NCT06914908 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-28T13:41:10.092Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT06914908
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.